Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"
BOSTON, Oct. 30, 2026 /PRNewswire/ -- Dr. Yang Liu, Director of Medicinal Chemistry at Revolution Medicines, Inc., and Dr. Kristof Pota, Senior Scientist, visited Medicilon's Nanhui R&D Center. Dr. Maosheng Duan, President of Medicilon's Drug Discovery and Pharmaceutical Research...
Covered in this story
Call it yourself
No calls on $RVMD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Revolution Medicines →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.